检索结果 - Dana E. Rathkopf

Refine Results
  1. 1
    Androgen Receptor Antagonists in Castration-Resistant Prostate Cancer

    Androgen Receptor Antagonists in Castration-Resistant Prostate Cancer 由 Dana E. Rathkopf, Howard I. Scher

    出版 2013
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    Apalutamide for the treatment of prostate cancer

    Apalutamide for the treatment of prostate cancer 由 Dana E. Rathkopf, Howard I. Scher

    出版 2018
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  3. 3
    Treatment of Advanced Prostate Cancer

    Treatment of Advanced Prostate Cancer 由 Min Yuen Teo, Dana E. Rathkopf, Philip W. Kantoff

    出版 2019
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  4. 4
    Treating the patient and not just the cancer: therapeutic burden in prostate cancer

    Treating the patient and not just the cancer: therapeutic burden in prostate cancer 由 Daniel E. Spratt, Neal D. Shore, Oliver Sartor, Dana E. Rathkopf, Kara Olivier

    出版 2021
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  5. 5
    Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862)

    Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862) 由 Deborah Bradley, Dana E. Rathkopf, Rodney L. Dunn, Walter M. Stadler, Glenn Liu, David C. Smith, Роберто Пили, James A. Zwiebel, Howard I. Scher, Maha Hussain

    出版 2009
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    A phase 2 study of intravenous panobinostat in patients with castration-resistant prostate cancer

    A phase 2 study of intravenous panobinostat in patients with castration-resistant prostate cancer 由 Dana E. Rathkopf, Joel Picus, Arif Hussain, Susan Ellard, Kim Nguyen, Thomas Nydam, E. Allen-Freda, Kaushal Mishra, Maria Grazia Porro, Howard I. Scher, George Wilding

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Phase I Dose-Finding Study of Weekly Docetaxel Followed by Flavopiridol for Patients with Advanced Solid Tumors

    Phase I Dose-Finding Study of Weekly Docetaxel Followed by Flavopiridol for Patients with Advanced Solid Tumors 由 Monica Fornier, Dana E. Rathkopf, Manisha H. Shah, S. Patil, Eileen M. O’Reilly, Archie Tse, C. Hudis, Robert A. Lefkowitz, David P. Kelsen, Gary K. Schwartz

    出版 2007
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Efficacy and Safety of Abiraterone Acetate in Elderly (75 Years or Older) Chemotherapy Naïve Patients with Metastatic Castration Resistant Prostate Cancer

    Efficacy and Safety of Abiraterone Acetate in Elderly (75 Years or Older) Chemotherapy Naïve Patients with Metastatic Castration Resistant Prostate Cancer 由 Matthew R. Smith, Dana E. Rathkopf, Peter F.A. Mulders, Joan Carles, Hendrik Van Poppel, Jinhui Li, Thian Kheoh, Thomas W. Griffin, Arturo Molina, Charles J. Ryan

    出版 2015
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    A phase II study of the dual mTOR inhibitor MLN0128 in patients with metastatic castration resistant prostate cancer

    A phase II study of the dual mTOR inhibitor MLN0128 in patients with metastatic castration resistant prostate cancer 由 Laura Graham, Kalyan Banda, Alba Torres, Brett S. Carver, Yu Chen, Katie Pisano, Greg Shelkey, Tracy Curley, Howard I. Scher, Tamara L. Lotan, Andrew C. Hsieh, Dana E. Rathkopf

    出版 2018
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Dermatological Adverse Events in Prostate Cancer Patients Treated with the Androgen Receptor Inhibitor Apalutamide

    Dermatological Adverse Events in Prostate Cancer Patients Treated with the Androgen Receptor Inhibitor Apalutamide 由 Alexander Pan, Rachel Reingold, Jimmy L. Zhao, Andrea P. Moy, Lukas Kraehenbuehl, George Dranitsaris, Sean M. McBride, Howard I. Scher, Marisa Kollmeier, Han Xiao, Dana E. Rathkopf, Mario E. Lacouture

    出版 2022
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Radiographic Progression-Free Survival as a Clinically Meaningful End Point in Metastatic Castration-Resistant Prostate Cancer

    Radiographic Progression-Free Survival as a Clinically Meaningful End Point in Metastatic Castration-Resistant Prostate Cancer 由 Dana E. Rathkopf, Tomasz M. Beer, Yohann Loriot, Celestia S. Higano, Andrew J. Armstrong, Cora N. Sternberg, Johann S. de Bono, Bertrand Tombal, Teresa Parli, Suman Bhattacharya, De Phung, Andrew Krivoshik, Howard I. Scher, Michael J. Morris

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Pan-cancer Analysis of CDK12 Alterations Identifies a Subset of Prostate Cancers with Distinct Genomic and Clinical Characteristics

    Pan-cancer Analysis of CDK12 Alterations Identifies a Subset of Prostate Cancers with Distinct Genomic and Clinical Characteristics 由 Bastien Nguyen, José Maurício Mota, Subhiksha Nandakumar, Konrad H. Stopsack, Emily S. Weg, Dana E. Rathkopf, Michael J. Morris, Howard I. Scher, Philip W. Kantoff, Anuradha Gopalan, Dmitriy Zamarin, David B. Solit, Nikolaus Schultz, Wassim Abida

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Phase 2 Study of the Safety and Antitumor Activity of Apalutamide (ARN-509), a Potent Androgen Receptor Antagonist, in the High-risk Nonmetastatic Castration-resistant Prostate Cancer Cohort

    Phase 2 Study of the Safety and Antitumor Activity of Apalutamide (ARN-509), a Potent Androgen Receptor Antagonist, in the High-risk Nonmetastatic Castration-resistant Prostate Can... 由 Matthew R. Smith, Emmanuel S. Antonarakis, Charles J. Ryan, William L. Berry, Neal D. Shore, Glenn Liu, Joshi J. Alumkal, Celestia S. Higano, Edna Chow Maneval, Rajesh Bandekar, Carla J. de Boer, Margaret K. Yu, Dana E. Rathkopf

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Phase I pharmacokinetic and biodistribution study with escalating doses of 223Ra-dichloride in men with castration-resistant metastatic prostate cancer

    Phase I pharmacokinetic and biodistribution study with escalating doses of 223Ra-dichloride in men with castration-resistant metastatic prostate cancer 由 Jorge A. Carrasquillo, Joseph A. O’Donoghue, Neeta Pandit‐Taskar, John L. Humm, Dana E. Rathkopf, Susan F. Slovin, Matthew J. Williamson, Kristine Peregrino Lacuna, Anne-Kirsti Aksnes, Steven M. Larson, Howard I. Scher, Michael J. Morris

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Repurposing Itraconazole as a Treatment for Advanced Prostate Cancer: A Noncomparative Randomized Phase II Trial in Men With Metastatic Castration-Resistant Prostate Cancer

    Repurposing Itraconazole as a Treatment for Advanced Prostate Cancer: A Noncomparative Randomized Phase II Trial in Men With Metastatic Castration-Resistant Prostate Cancer 由 Emmanuel S. Antonarakis, Elisabeth I. Heath, David C. Smith, Dana E. Rathkopf, Amanda L. Blackford, Daniel C. Danila, Serina King, Anja S. Frost, A. Seun Ajiboye, Ming Zhao, Janet Mendonca, Sushant K. Kachhap, Michelle A. Rudek, Michael A. Carducci

    出版 2013
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Safety and Antitumor Activity of Apalutamide (ARN-509) in Metastatic Castration-Resistant Prostate Cancer with and without Prior Abiraterone Acetate and Prednisone

    Safety and Antitumor Activity of Apalutamide (ARN-509) in Metastatic Castration-Resistant Prostate Cancer with and without Prior Abiraterone Acetate and Prednisone 由 Dana E. Rathkopf, Emmanuel S. Antonarakis, Neal D. Shore, Ronald Tutrone, Joshi J. Alumkal, Charles J. Ryan, Mansoor N. Saleh, Ralph J. Hauke, Rajesh Bandekar, Edna Chow Maneval, Carla J. de Boer, Margaret K. Yu, Howard I. Scher

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate cancer

    First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate can... 由 Diletta Bianchini, Aurelius Omlin, Carmel Pezaro, David Lorente, Roberta Ferraldeschi, Deborah Mukherji, Mateus Crespo, I. Figueiredo, Susana Miranda, Ruth Riisnaes, Andrea Zivi, Aby Buchbinder, Dana E. Rathkopf, Gerhardt Attard, Howard I. Scher, Johann S. de Bono, Daniel C. Danila

    出版 2013
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    Radiographic progression with nonrising PSA in metastatic castration-resistant prostate cancer: post hoc analysis of PREVAIL

    Radiographic progression with nonrising PSA in metastatic castration-resistant prostate cancer: post hoc analysis of PREVAIL 由 Alan H. Bryce, Joshi J. Alumkal, Andrew J. Armstrong, Celestia S. Higano, Peter Iversen, Cora N. Sternberg, Dana E. Rathkopf, Yohann Loriot, Johann S. de Bono, Bertrand Tombal, Sarang Abhyankar, Po‐Han Lin, Andrew Krivoshik, D. Phung, Tomasz M. Beer

    出版 2017
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    Phase I Study of ARN-509, a Novel Antiandrogen, in the Treatment of Castration-Resistant Prostate Cancer

    Phase I Study of ARN-509, a Novel Antiandrogen, in the Treatment of Castration-Resistant Prostate Cancer 由 Dana E. Rathkopf, Michael J. Morris, Josef J. Fox, Daniel C. Danila, Susan F. Slovin, Jeffrey H. Hager, Peter J. Rix, Edna Chow Maneval, Isan Chen, Mithat Gönen, Martin Fleisher, Steven M. Larson, Charles L. Sawyers, Howard I. Scher

    出版 2013
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302

    Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302 由 Johann S. de Bono, Matthew R. Smith, Fred Saad, Dana E. Rathkopf, Peter F.A. Mulders, Eric J. Small, Neal D. Shore, Karim Fizazi, Peter De Porre, Thian Kheoh, Jinhui Li, Mary B. Todd, Charles J. Ryan, Thomas W. Flaig

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: